BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie J, Huang S, Huang H, Deng X, Yue P, Lin J, Yang M, Han L, Zhang DK. Advances in the Application of Natural Products and the Novel Drug Delivery Systems for Psoriasis. Front Pharmacol 2021;12:644952. [PMID: 33967781 DOI: 10.3389/fphar.2021.644952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohd Zaid NA, Sekar M, Bonam SR, Gan SH, Lum PT, Begum MY, Mat Rani NNI, Vaijanathappa J, Wu YS, Subramaniyan V, Fuloria NK, Fuloria S. Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action. Drug Des Devel Ther 2022;16:23-66. [PMID: 35027818 DOI: 10.2147/DDDT.S326332] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
2 Zhang Q, Xie J, Li G, Wang F, Lin J, Yang M, Du A, Zhang D, Han L. Psoriasis treatment using Indigo Naturalis: Progress and strategy. J Ethnopharmacol 2022;:115522. [PMID: 35872288 DOI: 10.1016/j.jep.2022.115522] [Reference Citation Analysis]
3 Gao J, Shen X, Ko R, Huang C, Shen C. Cognitive Process of Psoriasis and Its Comorbidities: From Epidemiology to Genetics. Front Genet 2021;12:735124. [PMID: 34899832 DOI: 10.3389/fgene.2021.735124] [Reference Citation Analysis]
4 Shaif M, Kushwaha P, Usmani S, Pandey S. Exploring the potential of nanocarriers in antipsoriatic therapeutics. J Dermatolog Treat 2022;:1-11. [PMID: 35729857 DOI: 10.1080/09546634.2022.2089616] [Reference Citation Analysis]
5 Kim N, Lee S, Kang J, Choi YA, Jang YH, Jeong GS, Kim SH. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways. Molecules 2021;26:6086. [PMID: 34641629 DOI: 10.3390/molecules26196086] [Reference Citation Analysis]
6 Koycheva IK, Mihaylova LV, Todorova MN, Balcheva-Sivenova ZP, Alipieva K, Ferrante C, Orlando G, Georgiev MI. Leucosceptoside A from Devil's Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes. Molecules 2021;26:7014. [PMID: 34834106 DOI: 10.3390/molecules26227014] [Reference Citation Analysis]